Clinical isolates were tested four times using primers and probes specific for either mef(A/E), erm(A), erm(TR) or erm(B) genes. The erm(C) gene was not sought as its presence has only been reported in staphylococci. Figure 1 shows the characteristic melting peaks for the positive controls; similar peaks were produced by the clinical isolates. erm(TR) and erm(B) were detected as the only erythromycin resistance genes in 41 (67%) and five (8%), respectively, of clinical strains with the MLS B phenotype. All strains with the M-phenotype contained mef(A/E) only, while among those with the MLS B phenotype, seven (11%) possessed double mechanisms of resistance: erm(TR) + erm(B), erm(TR) + mef(A/E) or erm(B) + mef(A/E). Two (3%) clinical strains expressing MLS B phenotype were negative for erythromycin resistance genes. No isolate carried the erm(A) gene.
This assay, with the rapid boiling method for DNA extraction, provides results within 1 h of sample preparation. It is sensitive and specific, successfully identifying resistance genes in 97% of the erythromycin-resistant clinical strains of group B, C and G streptococci. With the increasing availability of Light-Cyclers, the assay can be used as a rapid tool for local, national and international surveillance of erythromycin resistance in streptococci, thereby guiding therapy.
In agreement with a previous study, 6 we found erm(TR) to be the most frequent resistance gene. However, for definitive erythromycin resistance genotyping, isolates should be tested for the most common mef and erm genes, as more than one resistance gene may be present. 4 Many of the existing PCR assays are multiplex, 3, 4 reducing the number of reactions required. The characteristic melting peaks detected in the different channels are being exploited in developing a multiplex assay, which will reduce further the turn-around time and cost. Sir, The most commonly cultured microorganisms in prostheticjoint infections are coagulase-negative staphylococci. 1 Resistance to b-lactam antibiotics is encoded by the mecA gene; this gene is carried on a mobile genetic element, the staphylococcal chromosome cassette mec (SCCmec). Loss or deletion of the mecA gene rarely occurs, mainly due to factors affecting the stability of SCCmec. Vancomycin may induce deletion of the mecA gene in Staphylococcus aureus, as reported in this journal last year. 2 We report the case of an implant-associated infection due to a methicillin-resistant Staphylococcus epidermidis which lost the mecA gene after prolonged treatment with glycopeptides.
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An 82-year-old man was admitted to our hospital because of a prosthetic-joint associated infection with a sinus tract, 4 months after implantation of a total hip prosthesis. S. epidermidis resistant to oxacillin, ciprofloxacin, trimethoprim/sulfamethoxazole, gentamicin, clindamycin, erythromycin, fusidic acid and rifampicin, but susceptible to tetracycline, teicoplanin and vancomycin grew in biopsies from periprosthetic tissue. Species identification was made using API ID 32 Staph system (bioMérieux, La Balme les Grottes, Montalieu Vercieu, France); the MIC of vancomycin was 2 mg/L determined by Etest (AB Biodisk, Solna, Sweden) in Mueller-Hinton (MH) agar. A spacer-free, two-stage exchange of the prosthesis with an 8 week interval was performed and antimicrobial chemotherapy was administered during the first 6 weeks. 1 The patient was treated with a 5.5 week course of vancomycin (1 g twice daily), followed by teicoplanin (400 mg once daily) for the remaining 4 days, after removal of the central venous catheter. On reimplantation, biopsies from periprosthetic tissue were obtained and vancomycin (1 g twice daily) was given for another 2 weeks, until cultures were reported to be negative.
Unfortunately, relapse occurred 4 months after reimplantation. Again, S. epidermidis was isolated, but showed two different phenotypes in susceptibility tests. While one strain was indistinguishable from the pathogen causing the primary infection, the second type was susceptible to oxacillin, but otherwise there was no difference in the resistance pattern. Both strains showed no increase in MIC of vancomycin, as revealed by Etest in MH agar. PCR for the mecA gene was negative in the second type, but positive in the original isolate. Interestingly, pulsed-field gel electrophoresis (PFGE) after SmaI digestion revealed only a slight difference between the two strains. The distance between two bands at 140 kb and at 160 kb was narrower in the mecApositive strain (Figure 1) , probably representing the location of the mecA gene. Vancomycin (1 g twice daily for 6 weeks) was administered during the implant-free-interval, and a complete recovery was made.
To our knowledge, in vivo loss of mecA gene in S. epidermidis after treatment has only been published in abstract form, without reporting any further details about antimicrobial agents and duration of therapy. 3 Acquiring methicillin resistance is attributed to intra-and interspecies transfer of SCCmec, 4 but little is known about the loss or deletion of the mecA gene. Long-term storage, high temperatures and UV radiation have been described to be factors influencing the stability of SSCmec in vitro. 2 Moreover, experiments have shown that coagulase-negative staphylococci exposed to glycopeptides may lose high-level resistance to oxacillin, without loss of the mecA gene. 5 Recently published findings indicate that the acquisition and/or loss of SCCmec in S. epidermidis, may occur in the region of the orfX gene. 6 Our case illustrates that the mecA complex may lose its stability after prolonged antimicrobial treatment.
